Bayer Asks High Court to Take $1.25 Million Roundup Appeal
Bayer AG said it’s seeking a US Supreme Court review of litigation over the weedkiller Roundup, its latest effort to get ...
Zacks Investment Research on MSN1d
Bayer's Vividion Initiates Dosing in Early-Stage Cancer Study
Bayer’s BAYRY wholly owned and independently operated subsidiary, Vividion Therapeutics, Inc, announced that the first ...
Yicai Global3d
Bayer Pharmaceuticals Prepares for a Landmark Year with Key Product Launches, Strategic Focus on China Amid Challenges
Bayer's AI Innovation Platform (AIIP), powered by Google Cloud technology, streamlines the development of AI-driven medical ...
Pharmabiz3d
Bayer heralds pipeline progress, blockbuster launches and advanced flagship products in cell-gene therapy
Bayer heralds pipeline progress, blockbuster launches and advanced flagship products in cell-gene therapy: Our Bureau, Bengaluru Wednesday, April 2, 2025, 14:50 Hrs [IST] Bayer Ph ...
The Financial Express3d
Bayer Pharma to expand cardiology, women’s health portfolios with new drugs this year
The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.
BioSpace5d
5 Big Pharmas Push Boundaries in Radiopharmaceuticals
While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...